SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " bio " 2,875 found 🔀 AI-powered Shuffle
Queen Latifah Says Biopic May Need 3 People to Play Her
The hip-hop icon wants performers who can capture her journey from Dana Owens to Grammy winner, Oscar nominee, producer, and entrepreneur.
Waltz Health and Fresenius Kabi Expand Direct Access to Biosimilars Through Waltz Connect Platform
/PRNewswire/ -- Waltz Health®, an EVERSANA® company developing technologies and services that support better-informed decisions on prescription care and...
High-Impact Experience: Getting Research Ready
With support from NC State's Packways High-Impact Experiences initiative, the Biochemistry Undergraduate Research and Training Program now offers students an experience with greater structure and intention.
Tiny Health Raises $33M To Explore What Gut Data Can Reveal About Future Health
Austin-based Tiny Health has raised $33 million in a Series B funding round led by B Capital to help it meet growing demand for its at-home microbiome tests.
The Beclowning of Scott Bessent
One iron law of current politics is that nobody who associates themselves with Donald Trump emerges with a shred of credibility. For some, that’s not a big loss — it’s not as if anyone respected Pete Hegseth even before he decided that the key to military success in an age of drones and AI was more testosterone. For others, however, the costs are real. I’m old enough to remember when Marco Rubio was widely considered a reasonable, thoughtful politician. Right now, however, my candidate for the biggest loser is Scott Bessent, the Secretary of the Treasury. Bessent started out with significant reputation to lose: When Trump selected him, this was the headline in the Financial Times: Jason Furman, Barack Obama’s chief economist, described him as a “credible Treasury secretary who has a real understanding of the global economy”. But Bessent has now transformed himself into the Baghdad Bob of bonds. Three weeks ago, after intervening (for reasons that remain somewhat unclear) to support the Japanese yen, Bessent boasted about his ability to move markets and dared investors to bet against his, declaring “I am the house now.” He then tried to push long-term interest rates down, buying 30-year U.S. Treasuries in a move some have compared to paying down part of your mortgage by running up your credit card balance. Here’s how that’s going so far: To get some perspective on how high interest rates have gone, here’s a longer-term perspective: We haven’t seen interest rates this high since the fading days of the dotcom bubble. Why are interest rates hitting new records? The backdrop, as I argued in last Sunday’s primer, is the huge AI-driven investment boom; more on that next week. But the immediate cause of the latest interest rate spike was Trump’s rejection of an Iranian proposal to end the war. This rejection sent crude oil prices, which for a while had fallen considerably, shooting back up: It’s notable, by the way, that oil prices remain high even though a significant amount of oil is now being shuttled through the Strait of Hormuz by night, on smaller vessels. That’s an interesting story, which has a lot to do with the fact that oil from the Hormuz shuttle runs must be transferred to larger vessels before being shipped to markets in Europe and Asia; around 15 percent of the world’s large crude carriers are now parked off the coast of Oman, waiting to be tanked up. This is creating a shipping crunch: But that’s a topic for another day. For now, the point is that with oil still high and refined products, especially diesel, still close to record levels, inflation will remain elevated. And this in turn means that the Federal Reserve will keep short-term interest rates high, an expectation that is feeding into longer-term rates. Hence Bessent’s bond-market humiliation. The truth is that Bessent might not have been able to get interest rates down even in the best of circumstances. But he certainly won’t get anywhere as long as Trump keeps believing that he can somehow convert his Iran debacle into a triumphant victory. And Trump will keep believing that as long as he is surrounded by sycophants who tell him what he wants to hear. Sycophants like, for example, Scott Bessent, who is predicting the imminent collapse of the Iranian economy, possibly within two weeks. Bessent is right to say that the embargo on Iranian oil exports is placing the country under great economic strain. But his implicit prediction that this will quickly produce a deal that Trump can call victory looks no more plausible than his boasts about the bond market. The big question now is, why would anyone with a reputation to lose work for Donald Trump? As the beclowning of Bessent shows, joining the Trump team won’t just damage your reputation; it will utterly destroy it.
Caris Life Sciences Unveils the Next Evolution of Liquid Biopsy with Enhanced Caris Assure
/PRNewswire/ -- Caris Life Sciences® (Caris), a leading AI TechBio company, today unveiled the enhanced Caris Assure®, a new evolution of liquid biopsy. By...
Primetime Review: That’s Entertainment?
If you decide to see Lance Oppenheim’s Primetime, it’s important to remember the title as you watch. Yes, this is a biopic of sorts about Chris Hansen and his work on To Catch a Predator, but it is more accurately about the quest for fame and using people’s trauma to attract ratings. True crime entertainment continues to have a prominent place in many people’s television habits, and this film asks us to examine what that means both for those whose stories have become our viewing pleasure and those of us watching. Primetime starts as Chris Hansen (Robert Pattinson) is told that his show, To Catch a Predator, is moving to a 9 PM spot opposite LOST. Chris and his producer, Andie (Merritt Wever), see this as an opportunity to make the program even more sensational, looking for bigger, more horrific predators. As part of their plan, they hire a young actor, Dan Plum (Skyler Gisondo), to play “Decoy Dan,” the person who greets the would-be predators who were catfished by Xavier Von Erck (Matthew Maher). Oppenheim, along with writers Ajon Singh and Luke Dittrich, is less concerned with an accurate retelling of the show as much as they are interested in interrogating the why of it all. That decision sometimes leaves Primetime feeling less like a biopic and more like a satirical look at the nature of programming like this. Visually, the movie is impressive. Oppenheim uses light and color effectively to cast Hansen as both villain and savior. Pattinson plays Hansen in an almost comical manner, as we see him wake his two young sons to watch a clip of the show, just to brag that he was moving into a prime spot on television. Even Andie struggles to accept a “nice” job when there is so much more fame to be found producing salacious true-crime content. Wever does an excellent job showing how the hunger for fame is not just in front of the camera, but in every aspect of the production. The heart of the movie, and the standout performance, belongs to Gisondo as Dan Plum. He is someone who just wants to get enough hours to be admitted into the Screen Actors Guild, and stumbles into this job without really knowing what it is. Throughout the film, we watch him suffer one trauma after another, ending with him witnessing the suicide of a District Attorney who is about to become the next unwitting star of Hansen’s show. If there is a sympathetic character in Primetime, it is Decoy Dan, and Gisondo plays him brilliantly. If you’re a fan of programming like To Catch a Predator, then Primetime will probably make you feel uncomfortable, and I think it’s worth sitting with that feeling and examining why we turn on shows that display the worst of humanity while we judge from our couches. Yes, it is correct to want to see people who would hurt children brought to justice, but perhaps it shouldn’t be something that we watch as entertainment. Rating: 3.5/5 This review originally appeared in The Dominion Post on September 25, 2026. MacGuffin or Meaning: Film & TV Reviews and Reflections is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
From wild rice to tarwi, researchers are exploring the health potential of Indigenous foods
A conference paper reviewed North American and Andean Indigenous foods, including Three Sisters crops, wild rice, native berries, tarwi, quinoa, and amaranth, and described their nutrients and bioactive compounds. Evidence for health effects remains limited for many of these foods, and the authors call for research developed with Indigenous communities that also supports traditional knowledge and food sovereignty.
Ethics Watchdogs To Investigate Whether Troubled Multnomah County Health Board Got Dubious Legal Advice
A Washington state attorney has been advising a Portland-area governance board on Oregon Public Meetings Law.
The Philosophy of Organizational Politics 2.0
Editor’s Note: This article is Part II of “The Philosophy of Organizational Politics: Power, Legitimacy, and the Integrity of Mission,” previously published in Oragark. We Are Not in Competition With Anyone: Conviction, Power, and the Purpose of Leadership By Dr. Prof. M. Mkhitar Moradian, PhD Bioanalyst In organizations some factions make
What If the Coffee Grounds We Throw Away Could Help Insulate Our Homes?
The grounds left behind from your daily cup of coffee could one day help insulate buildings. Scientists transformed spent coffee grounds into biodegradable biochar insulation that performs about as well as commercial foam. The material could give mountains of coffee waste a useful second life while helping reduce energy use. Now, researchers are working to determine how well it holds up over time.
Battle over progressive politics pits blue vs blue in this Seattle legislative district
Incumbent Sen. Jamie Pedersen and challenger Hannah Sabio-Howell talked to "Soundside" about their campaigns to represent the city's progressive district.
Bioblitz: Lakeshore Nature Preserve utilizes citizen science to document biodiversity
The University of Wisconsin Lakeshore Nature Preserve hosted its second annual Bioblitz event Sept. 26. The goal of the event was to document as many species at the preserve as possible over a 15-hour period, according to Lakeshore Nature Preserve Director Brad Herrick. With this documentation of everything within the 300-acre area, the preserve aims...
AI is everywhere. Should you use it for health advice?
The following expert commentary can be used by journalists and media organizations in their own publications and news coverage. Please attribute all quotes to Xiaoqian Jiang, PhD, chair of the Department of Health Data Science and Artificial Intelligence at McWilliams School of Biomedical Informatics at UTHealth Houston.
The Next Bioweapon Could Attack Our Genes Instead of Our Bodies. I Promise You We’re Not Ready for That.
The most devastating weapons conceived by humanity cause cellular damage as a side effect. What would happen if the genetic mutation itself were the nefarious goal?
Behind the Science with Paleontologist and Curator of Dinosauria Dr. Matthew Carrano
Is the 21st Century the real Age of Dinosaurs? Today, more paleontologists are discovering more dinosaur fossils from more places in the world than ever before. Our understanding of these amazing creatures has leapt forward while their popularity has surged. Museums sit at the junction of these phenomena. The Smithsonian has been a center for dinosaur research for more than a century, and its collections include many iconic and scientifically important specimens. Today, Smithsonian researchers continue to discover new dinosaurs, but they are also uncovering more information about the ones we already know and love. New techniques and approaches allow them to investigate aspects of dinosaur biology, ecology, and evolution in ways that would have been inconceivable to early paleontologists. The result is an ever-improving understanding of dinosaurs as living, breathing, and thriving animals. This month, go behind the science with paleontologist Dr. Matthew Carrano, Curator of Dinosauria at the National Museum of Natural History as he discusses new discoveries at home and abroad, in the field and in the museum. Registration is encouraged. Space is filled on a first come first served basis. ---------------- About the Series: Behind the Science A monthly after-hours series featuring NMNH scientists and researchers Each month, join the National Museum of Natural History for the new series, Behind the Science, where NMNH researchers share insights into their latest discoveries and explore the fascinating questions driving their work—from the origins of life to the future of our planet. Come learn what’s happening behind the scenes and how science shapes our understanding of the natural world. Programs take place in Q?rius, the Coralyn W. Whitney Science Education Center. Topics and speakers announced on a rolling basis, but save the dates now!
Mahony named Huck Chair in Genomics and AI
Shaun Mahony, professor of biochemistry and molecular biology in the Penn State Eberly College of Science, has been named the Dorothy Foehr Huck and J. Lloyd Huck Chair in Genomics and AI.
Tybee Island Marine Science Center releases loggerhead sea turtle ‘Ossie’ back into ocean
Biologists at the Tybee Island Marine Science Center released resident loggerhead sea turtle “Ossie” into the Atlantic Ocean on Saturday morning.
COTTON IN BEAUTY: A Sustainable, Sensorial & Science Backed Solution
This eBook examines how brands can leverage cotton's hypoallergenic, biodegradable and sensorial properties to create differentiated products, from facial wipes and reusable rounds to period care and adult incontinence.
Scientists Studied A Teenager With One Of The Rarest Memory Abilities Humans Can Have. Here’s What They Found
People with highly superior autobiographic memory have incredible recall for events in their own lives.
OMNIBUS X, a toxic proposal for health and biodiversity. MEPs should not vote for it: ECVC
Omnibus X is a legislative package which, under the usual pretext of simplification to streamline the pesticide approval system, weakens the precautionary principle at the heart of European pesticide regulation.
Good Science Is Not Enough: K4-MST To Explore At US BioTech Day, What Makes a Biotech Company Investable
An expert panel will examine why promising science is not enough and what biotech companies must prove to become financeable.
Good Science Is Not Enough: K4-MST To Explore At US BioTech Day, What Makes a Biotech Company Investable
An expert panel will examine why promising science is not enough and what biotech companies must prove to become financeable.
'Flat' Plymouth display frustrates boss Cleverley
Plymouth Argyle head coach Tom Cleverley says he is frustrated by his side's "flat" performance in their 1-0 loss to Burton Albion.
What your “Gut Feeling” is telling you about your health
Your gut microbiome is made of trillions of microbes such as bacteria, viruses, yeast, and fungi. In the past 10 to 15 years researchers have made big breakthroughs on how
Dirty hands, healthy life? What science really says may shock you - Futura-Sciences
The Rich Ecosystem Right at Our Fingertips For years, our skin was viewed as just a protective barrier. But in truth, it’s an ecosystem bursting with millions of invisible microorganisms: the cutaneous microbiome. It’s home to beneficial bacteria (like Staphylococcus epidermidis and Cutibacterium acnes), fungi (think Malassezia), viruses (such as...
South Texas Health System (@stxhealthsystem)
0 likes, 1 comments - stxhealthsystem on September 27, 2026: "Support Recovery, Strengthen Your Future: South Texas Health System, the Rio Grande Valley's largest integrated healthcare network, is seeking passionate physical therapy professionals to join its nationally recognized inpatient and outpatient rehabilitation teams at STHS McAllen, STHS Edinburg and STHS Heart. Physical therapists play a vital role in helping patients regain strength, mobility and independence following illness, injury or surgery. If you're passionate about empowering patients on their road to recovery, STHS offers an opportunity to make a lasting impact every day. Join a collaborative team dedicated to exceptional patient care and helping individuals return to the activities and quality of life they value most. Ready to move your career forward? View current openings and apply today at the link in our bio.".
Can Bionic Reading really help you read faster? Scientists put it to the test
Bionic Reading is a method of bolding certain letters in words that is purported to facilitate reading speed and comprehension. The idea is that guiding the eyes to focus on highlighted initial letters ...
The longevity boom is getting ahead of the science
Billions are pouring into anti-ageing biotech, but manipulating ageing has risks we are only beginning to understand.
Discovering a Design Argument Based on Biological Information
Charles Thaxton, along with Walter Bradley and Roger Olsen, wrote what arguably was the first official book of the intelligent design movement.
Saturn’s icy moon Enceladus may make alien life easier to find than scientists thought
Two studies suggest Saturn’s moon could both support methane-producing microbes and deliver concentrated traces of biology into space.
The Best Time To Eat Probiotic Foods for Gut Health and Immunity
While eating probiotic foods at a certain time of day may not impact their effectiveness, there are specific situations that could maximize their benefits, experts say.
Are your muscles thanks to a 47,000-year-old gene? Scientists stunned by discovery - Futura-Sciences
A genetic handshake across millennia The interbreeding between Neanderthals and modern humans didn’t just give anthropologists lots to write about—it left functional traces in our very DNA. An August 5th study published in the journal Current Biology shines a spotlight on one especially eye-catching legacy: a variant of the gene...
BioMedizone opens doors to science for underserved students
Before Anvi Palav was even old enough to carry a driver's license, she already had her sights set on changing the world – and a plan for how to do it.
New Open-Access Journal Puts Sustainable Polymers at the Center of Materials Science
Polymers are quietly the most successful materials story of the modern era, and the scientific community is now giving them a dedicated stage. Springer Nature has launched the Journal of Materials Science: Polymers, a new open-access title created to advance the science,
Metallurgy Enters a New Era as AI-Designed Alloys Redefine the Science of Metals
Metallurgy, the science that has underpinned human civilisation for more than six and a half thousand years, is undergoing a transformation so profound that researchers are calling it a new era for the field. From the first hammered copper tools of antiquity to the superalloys
Blood test could gauge if a baby has a dangerous infection in 15 minutes
Feverish babies in hospital are often assumed to have a serious bacterial infection and are treated with antibiotics. But a test that gauges whether the infection is bacterial or viral, which tend to be milder, could prevent unnecessary drug use
Seventy Years of Microbiome Science in China Signals a One Health Future
Trillions of microorganisms live on and inside the human body, in the soil that grows our food, and in the rivers, oceans and air that surround us. While microbes are most often discussed in the context of infection and disease, the vast majority of these organisms are neither
Information in Biology: A Mystery for Naturalism
Biology was giving us computer programming and symbolic codes which, by mapping functional structures to functional structures, exhibited a tacit semantics.
The 2011 Japan Tsunami Created Hybrid Fish, But They Almost Completely Disappeared
A changing world is pushing species boundaries in unusual ways, and the tsunami gave marine biologists a view of the process vastly sped up
This simple diet change could slow your biological age in just four weeks, study suggests
A simple change to the balance of your diet could reduce your biological age in just four weeks, according to a new study
I Had 5 Key Pillars of Health Tested, in Less Than Six Hours
With two Biograph locations, one in New York and one in the San Francisco bay area, the preventative care clinics evaluate assessments across five key pillars of health.
Margaret Qualley, Sabrina Carpenter Cast In Tom Holland's Fred Astaire Film
Margaret Qualley and Sabrina Carpenter have joined Tom Holland in Paul King's untitled Fred Astaire biopic, Deadline reports.
NeuroSense Provides Business Update and Progress for the First Half of 2026
/PRNewswire/ -- Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense" or the "Company"), a late-stage clinical biotechnology company focused on developing...
From fertility to menopause: Women's health workshop in Miami aims to empower women through education
Biohack-It is hosting a women’s health workshop and panel in Miami on Sunday, Oct. 4, featuring fertility specialist Dr. Natalie Crawford and OB-GYN Dr. Jessica Shepherd.
Biologists move unprecedented Orange County sea turtle eggs to protect them from hurricane-driven waves
The olive ridley sea turtle eggs will incubate at the Aquarium of the Pacific
Stunned scientists discover new wild cat species after a century—see the photos - Futura-Sciences
A Mysterious Cat in the Clouds High in the Andean forests—almost always wrapped in mist—a pint-sized cat was living its life unnoticed by the scientific community, although locals might have crossed its path many times. The story kicked off in 2016, when a Bolivian animal shelter contacted biologist Paola Nogales-Ascarrunz...
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time gene therapy for Sanfilippo syndrome type A, an inherited disease that progressively destroys cognitive function in young children. Until this week, there was no approved treatment at all. BioNTech’s lung cancer candidate shows promising results. […]
BioHealth Capital Region - Regional Life Sciences Roundup - September 25, 2026
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising…
Margaret Atwood donates $1-million to establish research chair for bird science
Donation will allow Western University to add a new hire to its biology faculty with the goal of advancing scientific knowledge about birds and bird migration
Pioneer of China NewCo model sued in US over trade secret misuse, double-dealing
A legal feud unfolding in New York is putting a spotlight on the work of a business development veteran who is credited for pioneering one of biopharma’s hottest dealmaking mechanism: the China “NewCo” model. In a lawsuit originally filed in New York state court and recently moved to federal court, China’s Lepu Medical Technology has alleged that biopharma business development consultant Su Zhang, who was hired to help shop its GLP-1 weight-loss candidates to Western partners, engaged in corporate double-dealing and trade secret leaks. According to the complaint, while acting as Lepu’s primary dealmaking liaison for a group of obesity and metabolic disease drug candidates, Zhang was secretly double-dipping as the acting chief business officer for a direct competitor, BrightGene Pharmaceutical. “She never adequately disclosed the role, never sought Lepu’s consent, and never proposed any safeguard,” Lepu alleged in its complaint, which was filed in July after Zhang’s consulting firm, CoDevCo, sought certain transaction-based success fees from its angry customer through an arbitration process in Singapore. Lepu, the parent company of Lepu Biopharma, has asked Zhang to pay back its $500,000 retainer and disgorge all benefits she received during the alleged breaches of fiduciary duty, plus other damages and relief. The company has also requested the court grant injunctions to protect Lepu’s trade secrets. The ill-fated partnership officially kicked off in December 2024, when Lepu tapped CoDevCo as its “exclusive business development mechanism” to identify collaborators for the company’s drug candidates. According to Lepu’s complaint, Zhang personally negotiated and signed the agreement as managing director for CoDevCo, which used her home address. Before the Lepu deal, Zhang made a name following a short stint as the global head of business development for Hengrui Pharmaceuticals. It was during her tenure that Hengrui signed a landmark deal granting exclusive rights for a portfolio of GLP-1 assets to Hercules, which was at that time newly established by a group of private equity and venture capital firms. In addition to the regular upfront and milestone payments, Hengrui also gained an equity stake in Hercules, which later became Kailera Therapeutics. The Hengrui-Hercules deal opened a new paradigm, where a Chinese biopharma company spins off certain early-stage assets to investors for further development through the creation of a new company abroad. The “NewCo” model quickly came into vogue as it allows Western investors to access high-potential assets originating from China at an early stage while giving the Chinese licensors an opportunity to reap long-term benefits through equity stakes in the new firms. The NewCo model proved its value when Kailera staged a record-breaking $625 million IPO on Nasdaq this April, merely two years into the Hengrui deal. Related Kailera CEO 'knew we were in a good spot' before obesity biotech's record-breaking $625M IPO On her LinkedIn page, Zhang described her work at Hengrui as “[b]uilding team and capability from the ground up,” forming NewCo and major pharma partnerships worth billions of dollars. Lepu clearly wanted that kind of track record to help boost its own cardiometabolic portfolio, which includes a range of assets for obesity, Type 2 diabetes, fatty liver disease and muscle preservation during weight loss treatment. “Lepu’s pipeline is very valuable, but only if Lepu could secure the right international partner to expand into the overseas market during the available commercial window,” the company argued in its complaint. The Chinese biotech said it had little knowledge of U.S. laws, customs or business practices in the business development field, and therefore “needed to rely entirely” on the expertise of Zhang and her team as the firm’s first engagement of a U.S.-based BD consultant. “Zhang’s dominating influence on the business development strategy is further evidenced by the fact that she personally controlled the business-development communications on behalf of Lepu with potential partners,” Lepu said in its complaint. After entering the deal, Zhang introduced Lepu to her four associates. According to Lepu’s version of events, all of them were allegedly employed at different time points to perform similar jobs at other Chinese companies that Lepu described as its competitors, while having access to Lepu’s confidential information. As such, Lepu described Zhang’s team as “a roster of individuals whose primary professional loyalty, by virtue of their concurrent full-time employment, ran to Lepu’s competitors.” As well as the specific examples set out in the case, a look at Lepu’s deals over the period suggests Zhang may have been involved in at least one transaction. During their partnership, Lepu, through its subsidiary Shanghai Minwei Biotechnology, also out-licensed its GLP-1/GIP/FGF21 agonist MWN105 to a NewCo called Sidera Bio in the fall of 2025. The deal included an upfront and near-term payment of $35 million, up to $1.01 billion in milestones, and a 9.99% stake in the Danish startup. It seems likely that Zhang facilitated the Minwei deal given that Lepu is on record as having used CoDevCo as its “exclusive business development mechanism.” The big shock for Lepu came in the form of a news article on June 25, 2025. The article, reporting on phase 2 data for BrightGene’s GLP-1/GIP receptor agonist BGM0504, identified Zhang as acting chief business officer of the Lepu rival. Blindsided by her association with BrightGene, Lepu confronted Zhang in July 2025. “Lepu was given assurances that there was nothing to be concerned about and told that Zhang would explain the matter to Lepu,” Lepu alleged in its complaint. “Zhang never did.” Lepu claimed that Zhang had the motive and opportunity to steer potential prospective partners toward BrightGene or other competitors. Later, in February 2026, one of Zhang’s associates joined BrightGene as the vice president for global business development, according to the complaint. Around the same time, Lepu sent written demand letters asking Zhang to account for her BrightGene role, identify what confidential data were shared with the rival firm, and provide any conflict-of-interest or firewall policies during the engagement. According to Lepu, neither CoDevCo nor Zhang answered the questions in their responses. Related Novo vs. KBP: How a $1.3B deal turned into a fraud accusation and an international legal fight In a motion to dismiss filed with the U.S. District Court in the Eastern District of New York on Sept. 4, Zhang’s legal team argued that Lepu’s agreement was signed with CoDevCo, and that an employee of the contractor does not owe fiduciary duties to the client. In its complaint, Lepu said: “That CoDevCo was the contracting entity does not insulate Zhang from personal liability for duties she personally undertook and personally breached.” Taking the argument one step further, the defending party argued that the consulting agreement “does not create a fiduciary relationship even between CoDevCo and Lepu; instead, it identifies CoDevCo as an independent contractor retained to market Lepu’s business to potential western partners.” Although CoDevCo was Lepu’s exclusive business-development contractor, there were no terms stipulating that the consulting firm should serve only Lepu, Zhang’s lawyer noted. As to Lepu’s claims that Zhang misappropriated trade secrets, the defendant argued that Lepu authorized the use of the information so Zhang’s team could perform their service per the agreement. In a rebuttal filed on Sept. 11, Lepu’s lawyer set out why they believe the Chinese biotech satisfied New York law’s misappropriation definition by alleging that the defendant used a trade secret “in breach of a duty or through improper means.” As an alternative to dismissing the suit, the defendant suggested the action should be stayed pending outcomes from the arbitration of a separate case in Singapore. While NewCo pioneer Zhang is defending her business arrangements, momentum behind the NewCo trend has continued unabated into 2026. Through August, Chinese biotech assets have spurred 15 NewCo deals this year, according to local trade publication PharmaDJ.
DelVal's Food Science Program Offers Hands-On Path to an In-Demand Industry
DelVal’s Food Science and Technology Program combines biology, chemistry, and food while preparing students for careers in a growing ...
ACSH in the media: British Medical Journal, RealClearScience (and Health), plus more podcasts
From a weedkiller paper that cannot carry the weight of its headline to a PFAS rule that treats cookware like a biohazard, we've been busy. Here’s a look at some of our recent media appearances, including in the British Medical Journal (BMJ), RealClearHealth, RealClearScience, SacTown Talks and the Health Policy Podcast.
Jonathan Fortney, Dan Costa honored by American Geophysical Union
Astronomy and astrophysics professor Jonathan Fortney receives 2026 Whipple Award and ecology and evolutionary biology professor Dan Costa named 2026 AGU Union Fellow
MSU College of Letters and Science Distinguished Professor to talk about pursuing passions and excellence in Oct. 8 lecture
Brian Bothner will reflect on a career advancing biomedical research, mentoring students and expanding scientific opportunities across Montana in a free, public lecture at the Museum of the Rockies on Oct. 8.
Intense Media Pressure an Emerging Challenge in CHO Business
Growing culture media requirements are becoming a major logistical and storage challenge for biopharmaceutical manufacturers.
Reedijk 'not an academic guy' despite doctorate
New Hibernian manager Marink Reedijk insists he is more a man of action than an academic despite having a philosophy doctorate in sports coaching. The Dutchman is only 35 but had already worked in coaching with Ajax and West Bromwich Albion, Roeselare, Vitesse and Anderlecht before leading Beveren to the Belgian second-tier title and promotion last season. "I'm not a really an academic guy," he told Hibs TV.
Blowhole nebulizer helps cure beluga whale's pneumonia
The vets needed to get creative when antibiotics weren’t moving the needle for her chronic condition.
AC Milan consider Adrien Rabiot contract extension a priority
AC Milan have reportedly made extending the contract of Adrien Rabiot (31) their top priority, according to reports in La Gazzetta dello Sport.Under contract with the Lombardy-based club until 2028, t...
'It's Not Great Content': Ex-Dragon Age Exec Says He'd Now Change or Ditch Several Key Moments From the Series
Former Dragon Age exec Mark Darrah has revealed what he'd change about BioWare's beloved fantasy series, after spending more than 20 years at the studio.
Generic, Biosimilar Medicines Saved US Health Care $496B in 2025
The Association for Accessible Medicines report, prepared with the IQVIA Institute, also reports $25.4 billion in biosimilar savings for the year.
In a New Anthropic Lab, A.I. Turns to Biology
Scientists at the company announced their first finding: a group of enzymes whose function is unknown.
Babis Kostoulas: A Deserved Nomination
On the 12th of June 2025, Brighton and Hove Albion signed Babis Kostoulas from Olympiacos. Since that moment, the Greek striker has treated Albion fans to tricks, bicycle kicks, and a thoroughly deserved Player of the Month nomination.
How Open Science Can Help Researchers Prepare for the Next Pandemic
NVIDIA is collaborating with organizations including Google DeepMind and the European Molecular Biology Laboratory’s European Bioinformatics Institute to release an open dataset of viral protein structures — giving scientists a head start against diseases.
NASA to Study Human Health, Performance During Crew-13 Mission
During NASA's SpaceX Crew‑13 mission aboard the International Space Station, astronauts will support a series of biomedical and human health performance...
The Best Brighton XI of the last 11 seasons
A recent social media trend has seen fans pick out one player from each of the last eleven seasons to build an ultimate starting lineup for their club. Today we attempt this trend for Brighton and Hove Albion.
From the Classroom to the Laboratory: Experiential Learning Shapes Food Science Student’s Future
Two semesters of experiential learning in Rutgers’ food packaging laboratory helped Daniel Burd transform classroom knowledge into award-winning research with real-world applications for the food industry. When Daniel Burd first arrived at Rutgers after earning an associate degree from Brookdale Community College, he knew he loved food science because it brought chemistry and biology to […]
Scientists find two tiny new snails with shells that close like doors
Scientists discovered two tiny new snail species in Montenegro, showing that even Europe still holds animals unknown to science. One lives in the threatened Komarnica Canyon, where a proposed hydropower reservoir could destroy habitat before its full biodiversity is understood.
Orange Boosts Life Science Portfolio With Biolevate Funding
Claire Scotton, VP Healthcare & Life Sciences at Orange, explains that Biolevate can accelerate life sciences innovation with trusted AI and workflows
China is excelling in health tech. That’s good news for the world
Ruby Wang, a physician and biotech consultant in the U.K., on her upcoming book on the emergence of China as a global health superpower.
Why do we get sleepy? Uncovering the science of sleep drive
Why do we get sleepy? A new preclinical study sheds some light on the science of sleep drive.
Milan want Rabiot to commit to long-term contract
Thursday’s reports claim that Milan want midfielder Adrien Rabiot to commit to a new long-term contract, and that the Frenchman could potentially end up seeing his career out in San Siro if he decid...
Under Trump, NIH funding disruptions have evolved. Here's what the numbers show
Stories of science funding being cut, labs shutting down and scientists losing jobs have flooded the media under Trump's administration. These six graphics show how those changes have affected U.S. biomedical research.
Signing Vuskovic was a masterstroke
Luka Vuskovic has been a "masterstroke" addition for Brighton, says former Premier League striker Chris Sutton. Brighton's record signing Vuskovic joined in the summer from Tottenham and has featured in all five of the Albion's Premier League matches so far. "What an incredible signing; £50m from Spurs - Spurs fans must be thinking 'why have we sold this guy?'", Sutton told BBC Radio 5 Live's Monday Night Club.
An AI model has found a new ‘CRISPR-like’ biological system. Here’s what it means for science
After coding, mathematics and chatbots, AI companies are setting their sights on the messy world of biology.
life – the bioRN Life Science Cluster magazine
Alliances for success – Heidelberg and the Rhine-Neckar region are among the most dynamic life science ecosystems in Europe.
Hands-on science can be cool
After spending many long days conducting experiments to find a new way to combat bacterial infections in crops, Misha Hegde and Mia Soleil Maurer have been rewarded with international recognition and access to top research facilities. But these are not typical scientists. They are 16-year-old German high school students.“Our supervisor told us that in order to start a project, you need to begin with either a question or a problem,” says Misha, adding that she and Mia had read about antibiotic resistance in certain plants being treated for bacterial infections. “We found out that antibiotics overuse is very common in agriculture,” explains Mia. “Our aim was to create an alternative to antibiotics and to try to raise awareness of the problem of overusing antibiotics.”Their subsequent research has focused on harnessing bacteriophages, the natural predators of bacteria, to eliminate pathogens threatening food crops treated with antibiotics. At the Schuldorf Bergstraße Jugend forscht MakerLab in Seeheim-Jugenheim, located in the German state of Hesse, they discovered a novel phage that infects the Rhizobium rhizogenes bacterium, which causes the hairy root disease that can reduce yields of tomatoes, carrots, soya beans and other food staples.The students believe their method could curb antibiotic use, while protecting plants from infections without disturbing the natural soil microbiome. “The application of phages is host-specific, so they would only kill the targeted pathogen or disease-causing bacteria,” explains Mia. It may also offer environmental benefits, since applying antibiotics can contaminate groundwater.Getting to this point has not been easy. The childhood friends admit to feeling frustrated when their trials did not yield the expected results. “We spent six months on our first experiment, just doing the same thing over and over and over again, to the point where we thought, is it even worth it? Why are we doing this?” Misha says. “You just need to be brave enough to take that first step and keep going.”The benefits of inquiry-based learningTheir determination has paid off. In 2025, the pair won first prize in biology at Jugend forscht, Germany’s national competition for young people interested in science, technology, engineering and mathematics. They were also among the winners of the German Research Foundation Europa-Preis, which is awarded to selected national winners at Jugend forscht, and took third place in the 2025 European Union Contest for Young Scientists.The Jugend forscht Foundation opens doors for young people to connect with scientists as well as industry professionals. Jessica Bönsch, executive director of the Foundation, sees Misha and Mia as prime examples of how young people can develop a deeper understanding of science through their own research projects. “The experience of working on your own research question is very important,” she explains, adding that “inquiry-based learning engages with real-life problems in a way that can be more motivating than traditional classroom teaching.”The Jugend forscht Foundation offers financial support through sponsor pools in Germany’s federal states. Some projects are developed in cooperation with student research centres, university labs or informal collaborative learning areas called makerspaces. Other activities start as hands-on “garage projects” and can grow within the Jugend forscht network and infrastructure.The Jugend forscht Foundation is also a partner of Science Comes to Town, an EU initiative to strengthen public awareness about science and create bridges between researchers and communities. The EU-financed project involves universities, research institutions and other stakeholders in three host cities — Brest (France), Kiel (Germany) and Split (Croatia).“It's so important for people not to live in a bubble, because I think science can be very scary if you misunderstand it,” Mia says of SCTT. The initiative’s aim of raising awareness about science is “absolutely amazing,” Misha adds. “I think it's the best way to kind of make science digestible for the public. In a world where misinformation in science is getting more radical, more dangerous, becoming more of a threat to the trust in scientific infrastructure and foundations, we need such programmes.”Misha and Mia also believe that SCTT can help break down gender stereotypes in science by encouraging young women to study and pursue careers in scientific fields. Both students have benefited from female mentors and encouragement they had when they were much younger. Mia’s love of science began with a class trip to a lab, while Misha — with a smile on her face — says she wanted to study history until “a teacher kind of coerced me into joining a school science club.”Recognition beyond EuropeIn May, Misha and Mia were among the finalists at the Regeneron International Science and Engineering Fair held in Phoenix, Arizona, and involving nearly 1,700 pre-university students from over 60 countries. “It was very crazy because there were so many people and so many teenagers interested in science,” Mia recalls. The event was also challenging. “It was eight hours of continuously presenting your project,” adds Misha.Attending the fair was a chance for the young women to see first-hand the value of international collaboration as well as how research cultures differ. “America is a bit more willing to take risks, and I think that's something we can learn about here in Europe,” Misha explains. However, she continues, “I think Europe has the talent, has the innovation and has the resources” to be competitive.Misha and Mia plan to continue their phage experiments in the new school year, inspired by the project’s hands-on nature and the support they receive from their supervisors. They have also attracted the interest of professional scientists and received invitations to leading research facilities, including the Centre for Synthetic Microbiology, jointly run by the University of Marburg and the Max Planck Institute for Terrestrial Microbiology in Germany. “It is so cool that we can do something to try to move the world in our school and at this age,” Mia says.After completing secondary school, Mia plans to study microbiology and pursue a career in medical research, focusing on Ebola and other infectious diseases. “This has been my dream for so long,” she says. Her friend Misha is interested in biological research with a focus on medicine. “I've gotten addicted to the process of going to the lab, planning out experiments, then failing, trying again,” Misha says. “I think there's just so much to be discovered, so much to be done.”The students' names and photos were published with the permission of their parents.Science|Business, which connects policymakers, academics and industry through its news reporting, analysis and events, is an SCTT partner.
Biophysical Therapeutics brings longevity science to skincare with its new IF1 brand
From equations and experiments in the laboratory to exclusive skincare for skin longevityWILMINGTON, Del., Sep. 23,
Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models
Recent advances in targeted therapies for pancreatic cancer have brought renewed attention to the Pancreatic Cancer Action Network.
Contrary to some reports, you don't have two brains
A bad press release makes a good excuse to look at how developmental biology works.
13th Session of the Plenary of the Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services (IPBES 13)
13th Session of the Plenary of the Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services (IPBES 13)
DHS plans ‘large investments’ in biosurveillance as it ramps up capabilities
The agency’s Science and Technology Directorate wants to add testing and evaluation sites, forge partnerships with industry and create internal roles to lead the work.
UT Health San Antonio scientists honored with BioMedSA Innovation Awards
Two scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), will be honored with 2026 BioMedSA Innovation in Healthcare and Bioscience awards. The awards recognize San Antonio leaders in the areas of research, clinical innovation, entrepreneurship and lifetime achievement, whose accomplishments improve lives […]
UT Health San Antonio scientists honored with BioMedSA Innovation Awards
Two scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), will be honored with 2026 BioMedSA Innovation in Healthcare and Bioscience awards. The awards recognize San Antonio leaders in the areas of research, clinical innovation, entrepreneurship and lifetime achievement, whose accomplishments improve lives […]
Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models
HOUSTON & SYDNEY, September 23, 2026--The Genialis Supermodel and Inventia's RASTRUM 3D cell model platform together will build models of PDAC that better represent tumor biology.
Troy Clarkson To Deliver Falmouth Forum Season Opener
Author and columnist Troy Clarkson will present the first talk of the Marine Biological Laboratory’s 2026-27 Falmouth Forum series.
Upcoming opportunities
🔬 Know a scientist whose sustained service to ASBMB and professional accomplishments have advanced the molecular biosciences? Consider nominating them as an ASBMB Fellow.
Could Proteins Become the Next Tool in Forensic Science?
Researchers reviewed how forensic proteomics uses mass spectrometry to analyze proteins in hair, bone, fingerprints, and body fluids. The approach can recover biological and contextual information when DNA is limited.
Wildlife management should be based on science not emotion (Opinion)
Wildlife research is essential because it protects biodiversity, guides conservation policies, and helps humans understand complex ecosystems. Without that research wildlife conservation/management and human/wildlife conflict mitigation would be equal to swinging a plastic pool noodle...
Kostoulas & Vuskovic shining for high-flying Seagulls
Brighton are flying high under the youngest manager in the top flight after five games of the Premier League season. Fabian Hurzeler guided his side to a 3-0 victory against Arsenal on the 125-year anniversary of the club in style - and the Seagulls sit in a very pleasing third place in the table. Former Brighton midfielder Warren Aspinall told Radio Sussex's Albion Unlimited podcast that the Gunners were "out-thought and out-battled".
New schizophrenia treatments, AI in mental health among topics at inaugural symposium in Roanoke
The two-day gathering on precision therapeutics will be held at the Fralin Biomedical Research Institute at VTC.
Donald Trump Wants a Vance-Rubio Ticket in 2028, Says Ari Emanuel
Emanuel also believes David Ellison’s doing right by an independent press.
What links smoking, body fat, mental health, genes, and heart risk? Inflammation may be part of the answer
In a large UK Biobank study, higher levels of the chronic inflammation marker GlycA were associated with smaller heart chambers, thicker heart walls, impaired diastolic function, reduced stroke volume, and a 43% higher risk of major adverse cardiovascular events in the highest versus lowest GlycA group. Genetic susceptibility also modified the associations between environmental exposures, inflammation, and cardiovascular risk, while inflammatory proteins in the IL-1, TNF, and IL-6 pathways statistically mediated several of these associations.
Merck Life Science Expands Bengaluru Manufacturing with €13 Million Investment
Merck Life Science is expanding its manufacturing capabilities in Bengaluru with an investment of approximately €13 million, strengthening the company’s ability to supply critical materials to customers across India and the wider Asia-Pacific region. The expansion at Merck Life Science’s Jigani site in Bengaluru will introduce biological buffer manufacturing alongside the facility’s established chemistry capabilities. The investment is designed to enable faster and more reliable access to critical materials used by customers across research, diagnostics, biotechnology and biopharmaceutical manufacturing. The development further advances Merck Life Science’s “in-region, for-region” approach, under which the company is expanding manufacturing capabilities closer to the markets and customers it serves. By adding biological buffer production in India, the Jigani expansion will broaden the site’s manufacturing capabilities while strengthening Merck Life Science’s regional supply infrastructure for the rapidly developing life sciences sector across India and Asia-Pacific. The company said the expansion reflects both the contribution of its teams and its collaboration with government and industry stakeholders. Merck Life Science acknowledged the support of India’s Department for Promotion of Industry and Internal Trade (DPIIT), the German Embassy New Delhi, and Invest India in helping strengthen life science manufacturing capabilities in the region. The investment comes as India continues to expand its role across pharmaceutical, biotechnology, diagnostics and biomanufacturing value chains, increasing demand for dependable regional access to materials supporting research and manufacturing operations. The Bengaluru expansion reinforces Merck Life Science’s focus on building manufacturing capacity within Asia-Pacific and supporting customers through a more regionalised supply network.
Justice Kagan rejects surrogate’s request for intervention in custody dispute
The baby’s biological parents said that high court intervention would only cause chaos and confusion.
Justice Kagan rejects surrogate’s request for intervention in custody dispute
The baby’s biological parents said that high court intervention would only cause chaos and confusion.
Quechan filmmaker explores Native sciences in PBS 'NOVA' episode
The PBS science series "NOVA" will explore Indigenous sciences and how traditional ecological knowledge has nurtured biomes and ecosystems, developed navigation systems using the stars and seas and domesticated foods now consumed worldwide in a new episode featuring Navajo hogan builders and created by a Quechan filmmaker.